Dipropylacetate (sodium valproate) and carbamazepine : a suspicious anticonvulsant combination
Lhermitte, F.; Marteau, R.; Serdaru, M.
La Nouvelle Presse Medicale 7(41): 3780
1978
ISSN/ISBN: 0301-1518 PMID: 366563 Document Number: 130389
Document emailed within 1 workday
Related Documents
Gensburger, C.; Simler, S.; Ciesielski, L.; Mandel, P. 1978: Effect of sodium n-dipropylacetate (sodium valproate) on GABA level of neuronal and glial cells in culture Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 172(4): 701-706Soliman, G.A.; Abla Abd; el-Meguid 1999: Effects of antiepileptic drugs carbamazepine and sodium valproate on fertility of male rats Deutsche Tierärztliche Wochenschrift 106(3): 110-113
Levy, R.H.; Moreland, T.A. 1984: Clinical pharmacokinetics of sodium valproate, carbamazepine and phenytoin. Level-dose ration and interactions Schweizerische Rundschau für Medizin Praxis 73(6): 159-163
Vaz, J.; Kulkarni, C.; David, J.; Joseph, T. 1998: Influence of caffeine on pharmacokinetic profile of sodium valproate and carbamazepine in normal human volunteers Indian Journal of Experimental Biology 36(1): 112-114
Kulkarni, C.; Vaz, J.; David, J.; Joseph, T. 1995: Aminophylline alters pharmacokinetics of carbamazepine but not that of sodium valproate--a single dose pharmacokinetic study in human volunteers Indian Journal of Physiology and Pharmacology 39(2): 122-126
Belkina, L.M.; Korchazhkina, N.B.; Kamskova, I.G.; Fomin, N.A. 1997: The cardioprotective action of the anticonvulsant preparation sodium valproate in disorders of cardiac contractile function caused by acute myocardial infarct in rats Patologicheskaia Fiziologiia i Eksperimental'naia Terapiia 2: 18-21
Marescaux, C.; Micheletti, G.; Rumbach, L.; Warter, J.M. 1981: Confusional state after addition of a third antiepileptic drug to a phenobarbital-sodium valproate combination La Nouvelle Presse Medicale 10(15): 1237
Ciesielski, L.; Simler, S.; Mandel, P. 1981: Effect of sodium dipropylacetate on experimental convulsions produced by pentetrazole and picrotoxin Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 175(1): 109-113
Simler, S.; Randrianarisoa, H.; Lehmann, A.; Mandel, P. 1971: Effects of audiogenic seizures and of sodium n-dipropylacetate on energy-rich phosphorous compounds in mice brains Journal de Physiologie 63(6): 285A-286A
Kulkarni, C.; Joseph, T.; David, J. 1989: Inhibition of anticonvulsant action of carbamazepine by aminophylline and caffeine in rats Indian Journal of Experimental Biology 27(12): 1048-1051
Kadlimatti, S.H.; Nadig, R.S.; Somaja, L.; Joseph, T.; David, J. 1988: Influence of dopaminergic receptor supersensitivity on anticonvulsant action of carbamazepine Indian Journal of Physiology and Pharmacology 32(4): 285-288
Otoom, S.; Bakhiet, M.; Khan, A.; Sequeira, R. 2006: Prolonged use of phenytoin, carbamazepine or valproate monotherapy on plasma levels of folate and B(12): a comparison between epileptic patients with or without cardiovascular disorders Neuro Endocrinology Letters 27(1-2): 85-88
Kapetanovic, I.M.; Kupferberg, H.J. 1984: Nafimidone, an imidazole anticonvulsant, and its metabolite as potent inhibitors of microsomal metabolism of phenytoin and carbamazepine Drug Metabolism and Disposition: the Biological Fate of Chemicals 12(5): 560-564
Yan, Q.S.; Mishra, P.K.; Burger, R.L.; Bettendorf, A.F.; Jobe, P.C.; Dailey, J.W. 1992: Evidence that carbamazepine and antiepilepsirine may produce a component of their anticonvulsant effects by activating serotonergic neurons in genetically epilepsy-prone rats Journal of Pharmacology and Experimental Therapeutics 261(2): 652-659
Hoffman, L.M. 1982: Sodium valproate and thrombocytopenia Canadian Medical Association Journal 126(4): 358-359
Barros, H.M.; Barros, E.J.; Carvalhaes, J.T. 1986: Acute pancreatitis associated with the use of sodium valproate Amb: Revista da Associacao Medica Brasileira 32(1-2): 33-34
Hernández, M.A.; Valencia, M.E.; Castillo, R.; Anciones, B. 1988: Sodium valproate in the treatment of choreoathetosis Medicina Clinica 90(12): 516
Schmutz, M.; Olpe, H.R.; Koella, W.P. 1979: Central actions of valproate sodium Journal of Pharmacy and Pharmacology 31(6): 413-414
Löscher, W.; Hönack, D. 1991: Anticonvulsant and behavioral effects of two novel competitive N-methyl-D-aspartic acid receptor antagonists, CGP 37849 and CGP 39551, in the kindling model of epilepsy. Comparison with MK-801 and carbamazepine Journal of Pharmacology and Experimental Therapeutics 256(2): 432-440
Leary, P.M.; Morris, S. 1980: Clinical experience with sodium valproate in children South African Medical Journal 57(21): 866-867